Wednesday, June 19, 2013
3:07 p.m. PDT
Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Gaucher's Disease published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-3 of 3
» View latimes.com items only
    Feb 26, 2010 | Los Angeles Times

  1. FDA formally approves new drug for Gaucher disease

    Booster Shots
    The Food and Drug Administration on Friday formally approved a new drug called velaglucerase alfa for injection (tradenamed VPRIV) for treatment of the rare genetic disorder Gaucher disease. The agency has already been allowing the company to ship the...
    2. Apr 18, 2009 |Story| Los Angeles Times

  2. Jewish legacy inscribed on genes?

    Gregory Cochran has always been drawn to puzzles. This one had been gnawing at him for several years: Why are European Jews prone to so many deadly genetic diseases?
    Los Angeles Times Staff Writer
    Gregory Cochran has always been drawn to puzzles. This one had been gnawing at him for several years: Why are European Jews prone to so many deadly genetic diseases? Tay-Sachs disease. Canavan disease. More than a dozen more. It offended Cochran's sense...

    Tags: Applied Physics, Judaism, Book, Education, National Institutes of Health

    3. Aug 1, 2012 |Story| Chicago Tribune

  3. What drugs are going generic this year and next

    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic Pharmaceutical Association.
    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic...

    Tags: Bipolar Disorder, Avandia (drug), Actos (drug), Drugs and Medicines, Behavioral Conditions

Advertisement